132 related articles for article (PubMed ID: 37226477)
1. An International Survey of Genitourinary and Renal Pathologists Regarding Evaluation of the Non-Neoplastic Parenchyma in Kidney Cancer Specimens.
Paik J; Ellis CL; Henriksen KJ; Chang A
Int J Surg Pathol; 2024 Apr; 32(2):273-278. PubMed ID: 37226477
[TBL] [Abstract][Full Text] [Related]
2. Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases.
Henriksen KJ; Meehan SM; Chang A
Am J Surg Pathol; 2007 Nov; 31(11):1703-8. PubMed ID: 18059227
[TBL] [Abstract][Full Text] [Related]
3. Medical renal disease in tumor nephrectomies: The silent killer.
Tewari R; Bajaj R; Bharadwaj R
Saudi J Kidney Dis Transpl; 2018; 29(1):50-56. PubMed ID: 29456207
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Peritumoral Atrophic Band and Nonneoplastic Renal Parenchyma in Radical Nephrectomy Specimens.
Dernell C; Bhasin B; Iczkowski KA; Gallan AJ
Am J Clin Pathol; 2021 Oct; 156(5):913-919. PubMed ID: 34075420
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure.
Bijol V; Mendez GP; Hurwitz S; Rennke HG; Nosé V
Am J Surg Pathol; 2006 May; 30(5):575-84. PubMed ID: 16699311
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of nontumoral renal pathologies in tumor nephrectomies: nontumoral renal parenchyma changes.
Sarsık B; Simşir A; Yılmaz M; Yörükoğlu K; Sen S
Ann Diagn Pathol; 2013 Apr; 17(2):176-82. PubMed ID: 23142019
[TBL] [Abstract][Full Text] [Related]
7. Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated.
Henriksen KJ; Meehan SM; Chang A
Arch Pathol Lab Med; 2009 Jul; 133(7):1012-25. PubMed ID: 19642728
[TBL] [Abstract][Full Text] [Related]
8. Nonneoplastic renal cortical scarring at tumor nephrectomy predicts decline in kidney function.
Salvatore SP; Cha EK; Rosoff JS; Seshan SV
Arch Pathol Lab Med; 2013 Apr; 137(4):531-40. PubMed ID: 23544942
[TBL] [Abstract][Full Text] [Related]
9. More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimens.
Kläger JP; Al-Taleb A; Pavlovic M; Haitel A; Comperat E; Fajkovic H; Kikić Ž; Kain R; Kozakowski N
J Nephrol; 2021 Dec; 34(6):1833-1844. PubMed ID: 33900582
[TBL] [Abstract][Full Text] [Related]
10. [Basic nephropathology for pathologists-part 2 : Non-inflammatory lesions].
Gaspert A; Büttner-Herold M; Amann K
Pathologie (Heidelb); 2023 Jul; 44(4):261-274. PubMed ID: 37368052
[TBL] [Abstract][Full Text] [Related]
11. Does the Renal Parenchyma Adjacent to the Tumor Contribute to Kidney Function? A Critical Analysis of Glomerular Viability in Partial Nephrectomy Specimens.
Khemees TA; Lam ET; Joehlin-Price AS; Mortazavi A; Phillips GS; Shabsigh A; Sharp DS; Zynger DL
Urology; 2016 Jan; 87():114-9. PubMed ID: 26505834
[TBL] [Abstract][Full Text] [Related]
12. Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens.
Garcia-Roig M; Gorin MA; Parra-Herran C; Garcia-Buitrago M; Kava BR; Jorda M; Soloway MS; Manoharan M; Ciancio G
World J Urol; 2013 Aug; 31(4):835-9. PubMed ID: 21691720
[TBL] [Abstract][Full Text] [Related]
13. Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens.
Wang X; Liu Q; Kong W; Huang J; Chen Y; Huang Y; Zhang J
BMC Cancer; 2017 Dec; 17(1):900. PubMed ID: 29282004
[TBL] [Abstract][Full Text] [Related]
14. Bystander LECT2 amyloidosis in tumor nephrectomy.
Gallan AJ; Bhasin-Chhabra B; Kilari D; Johnson S; D'Souza A
CEN Case Rep; 2023 Feb; 12(1):104-109. PubMed ID: 35986199
[TBL] [Abstract][Full Text] [Related]
15. The pathological evaluation of nonneoplastic kidney disorder in tumor nephrectomy specimens.
Noroozinia F; Makhdoomi K; Behnamfard H; Mohammadi S; Dindarian S; Bagheri M; Mohammadi H
Saudi J Kidney Dis Transpl; 2018; 29(3):586-590. PubMed ID: 29970734
[TBL] [Abstract][Full Text] [Related]
16. The Importance of Nephropathology in Kidney Cancer.
Henriksen KJ; Chang A
Semin Nephrol; 2020 Jan; 40(1):69-75. PubMed ID: 32130968
[TBL] [Abstract][Full Text] [Related]
17. A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.
Rini BI; Plimack ER; Takagi T; Elson P; Wood LS; Dreicer R; Gilligan T; Garcia J; Zhang Z; Kaouk J; Krishnamurthi V; Stephenson AJ; Fergany A; Klein EA; Uzzo RG; Chen DY; Campbell SC
J Urol; 2015 Aug; 194(2):297-303. PubMed ID: 25813447
[TBL] [Abstract][Full Text] [Related]
18. Histological Changes in the Background Renal Parenchyma in Neoplastic Nephrectomies and Nephroureterectomy: A 10-Year Single-Center Experience.
Al Zahrani RA
J Microsc Ultrastruct; 2023; 11(2):103-106. PubMed ID: 37448820
[TBL] [Abstract][Full Text] [Related]
19. Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations.
Trpkov K; Grignon DJ; Bonsib SM; Amin MB; Billis A; Lopez-Beltran A; Samaratunga H; Tamboli P; Delahunt B; Egevad L; Montironi R; Srigley JR;
Am J Surg Pathol; 2013 Oct; 37(10):1505-17. PubMed ID: 24025521
[TBL] [Abstract][Full Text] [Related]
20. Breast Specimen Processing and Reporting With an Emphasis on Margin Evaluation: A College of American Pathologists Survey of 866 Laboratories.
Guidi AJ; Tworek JA; Mais DD; Souers RJ; Blond BJ; Brown RW
Arch Pathol Lab Med; 2018 Apr; 142(4):496-506. PubMed ID: 29328775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
